NOVEL PAX3::MAML3 FUSION IDENTIFIED IN ALVEOLAR RHABDOMYOSARCOMA: USING DNA METHYLATION TO EXPANDE THE GENETIC SPECTRUM OF "FUSION POSITIVE" CASES

Author(s)

• 

  Karen J. Fritchie, MD

  Professor
  Cleveland Clinic
  Rocky River, Ohio, United States

  Slides

Co-Author(s)

• 

  Josephine K. Dermawan, MD, PhD

  Attending Pathologist
  Cleveland Clinic
  Cleveland, Ohio, United States
• 

  John M. Gross, md

  Assistant Professor of Pathology and Orthopedic Surgery
  Johns hopkins
  baltimore, Maryland, United States
• EB

  Ezra Baraban, md

  Johns hopkins
  baltimore, Maryland, United States
• CP

  Christine A. Pratilas, MD

  Associate Professor of Oncology & Pediatrics
  Johns Hopkins University School of Medicine
  Baltimore, Maryland, United States
• 

  Matteo Trucco, MD

  Associate Professor
  Cleveland Clinic
  Cleveland, Ohio, United States
• ws

  wenyue sun, phD

  nih
  bethesda, Maryland, United States
• FB

  Frederic G. Barr, MD PhD

  Senior Investigator
  National Cancer Institute
  Bethesda, Maryland, United States
• 

  Felipe D'Almeida Costa, MD (he/him/his)

  Pathologist
  A.C.Camargo Cancer Center
  Sao Paulo, Sao Paulo, Brazil
• FM

  Faizan Malik, md

  st judes
  memphis, Tennessee, United States